Rapamycin Blocks IL-2-Driven T Cell Cycle Progression While Preserving T Cell Survival
- 31 May 2001
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 27 (3) , 572-585
- https://doi.org/10.1006/bcmd.2001.0420
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Expression of a Novel Isoform of Cyclin I in Human TestisBiochemical and Biophysical Research Communications, 1998
- Murine betaglycan primary structure, expression and glycosaminoglycan attachment sitesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1998
- Identification of an Essential Cis-Element Near the Transcription Start Site for Transcriptional Activation of the Proliferating Cell Nuclear Antigen GenePublished by Elsevier ,1996
- Rapamycin Selectively Blocks Interleukin-2-induced Proliferating Cell Nuclear Antigen Gene Expression in T LymphocytePublished by Elsevier ,1995
- The regulation and function of p21ras during T-cell activation and growthImmunology Today, 1995
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- lnterleukin-2 programs mouse αβ T lymphocytes for apoptosisNature, 1991
- Requirement of Nuclear Prolactin for Interleukin-2—Stimulated Proliferation of T LymphocytesScience, 1991
- Contingent Genetic Regulatory Events in T Lymphocyte ActivationScience, 1989
- Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.The Journal of Experimental Medicine, 1980